Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combinations comprising anti-FOLR1 immunoconjugates

Therapeutic combinations comprising anti-FOLR1 immunoconjugates

US Patent 10172875 · Granted Jan 8, 2019

Estimated economic value: $12,191,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2025
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2025
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2025
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations2022
Therapeutic combinations comprising anti-FOLR1 immunoconjugates2021
Therapeutic combinations comprising anti-FOLR1 immunoconjugates2021
Therapeutic combinations comprising anti-FOLR1 immunoconjugates2021
Methods for inducing or enhancing an immune response by administering agonistic 2020
Methods of inducing or enhancing an immune response in a subject having cancer b2018
GITR antibodies and methods of inducing or enhancing an immune response2016